| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 38 |
| 1 | PEGFILGRASTIM | 35 |
| 2 | EVOLOCUMAB | 27 |
| 3 | CLONIDINE TRANSDERMAL SYSTEM | 10 |
| 4 | CLONIDINE | 9 |
| 5 | LOSARTAN | 9 |
| 6 | DICLOFENAC SODIUM | 8 |
| 7 | NORELGESTROMIN AND ETHINYL ESTRADIOL | 8 |
| 8 | OCTREOTIDE ACETATE | 8 |
| 9 | GRANISETRON | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HISTAMINE | 1 | 0.0069 |
| 1 | CLONIDINE TRANSDERMAL SYSTEM | 10 | 0.0047 |
| 2 | NORELGESTROMIN AND ETHINYL ESTRADIOL | 8 | 0.0043 |
| 3 | SCOPOLAMINE TRANSDERMAL SYSTEM | 1 | 0.0037 |
| 4 | PEGFILGRASTIM | 35 | 0.0029 |
| 5 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 6 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 7 | BODY CLEANSER | 1 | 0.0014 |
| 8 | SELEGILINE | 3 | 0.0010 |
| 9 | PALONOSETRON HYDROCHLORIDE | 5 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 46 |
| 1 | Leukocyte Growth Factor [EPC] | 35 |
| 2 | PCSK9 Inhibitor [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 16 |
| 4 | Progestin [EPC] | 11 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 10 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 8 | Alkylating Drug [EPC] | 8 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | PCSK9 Inhibitor [EPC] | 27 | 0.0010 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 3 | 0.0010 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 6 | GLP-2 Analog [EPC] | 4 | 0.0003 |
| 7 | Progesterone [EPC] | 6 | 0.0003 |
| 8 | Estrogen [EPC] | 46 | 0.0002 |
| 9 | Leukocyte Growth Factor [EPC] | 35 | 0.0002 |